|  Help  |  About  |  Contact Us

Publication : RGS12 Is a Novel Critical NF-κB Activator in Inflammatory Arthritis.

First Author  Yuan G Year  2020
Journal  iScience Volume  23
Issue  6 Pages  101172
PubMed ID  32512384 Mgi Jnum  J:311522
Mgi Id  MGI:6717638 Doi  10.1016/j.isci.2020.101172
Citation  Yuan G, et al. (2020) RGS12 Is a Novel Critical NF-kappaB Activator in Inflammatory Arthritis. iScience 23(6):101172
abstractText  Rheumatoid arthritis (RA) is the most common inflammatory disease, which currently lacks effective treatment. Here, we discovered that the Regulator of G Protein Signaling 12 (RGS12) plays a key role in regulating inflammation. Transcriptional and protein analysis revealed that RGS12 was upregulated in human and mouse RA macrophages. Deletion of RGS12 in myeloid lineage or globally inhibits the development of collagen-induced arthritis including joint swelling and bone destruction. Mechanistically, RGS12 associates with NF-kappaB(p65) to activate its phosphorylation and nuclear translocation through PTB domain, and NF-kappaB(p65) regulates RGS12 expression in a transcriptional manner. The nuclear translocation ability of NF-kappaB(p65) and RGS12 can both be enhanced by cyclooxygenase-2 (COX2). Furthermore, ablation of RGS12 via RNA interference significantly blocks the inflammatory process in vivo and in vitro. These results demonstrate that RGS12 plays a critical role in the pathogenesis of inflammatory arthritis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

1 Bio Entities

Trail: Publication

0 Expression